Studies genes in Chinese patients with inflammatory bowel disease
Looks for new genes in Chinese people with Crohn's disease or ulcerative colitis.
Plain-language title generated from the registry record
Registry title: GWA Study in Patients With Inflammatory Bowel Disease
Key facts
- Where
- Hong Kong, Hong KongSee the site
Where in Hong Kong
- Prince of Wales HospitalHong Kong, Hong KongTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Chinese University of Hong Kong
- Trial code
- NCT01140789
- Record updated
- 8 February 2023
- Original description
The aim of this study is to identify new genes in Chinese patients that help investigators to understand the biological pathway and functions in a population in whom the incidence of Inflammatory Bowel Disease (IBD) is increasing. And to explore the genetic variations in Chinese patients with IBD.Read full original descriptionShow less
Genome Wide Association (GWA) Study in Chinese Patients With Inflammatory Bowel Disease
The aim of this study is to identify new genes in Chinese patients that help investigators to understand the biological pathway and functions in a population in whom the incidence of Inflammatory Bowel Disease (IBD) is increasing. And to explore the genetic variations in Chinese patients with IBD.
Inclusion: Age 18 or above; Informed consent given by patient or family; Case group (IBD patients) Diagnosis of Crohn's disease or ulcerative colitis defined by endoscopy, radiology and histology; Control group (non-IBD cases) Ethically, sex and aged-matched controls attending clinics or endoscopy for functional upper gastrointestinal diseases or screening colonoscopy.
Exclusion: Controls will be excluded if they have previously been diagnosed with IBD or if they have a first or second degree relative with IBD; No consent.